Top Medical Stocks are CI, COV, AMLN : by Penny Stock Pick Report

CIGNA Corporation (NYSE:CI)   is amongst the top gainer in the early few hours. The stock has surged 0.84% and is trading at $38.24 with a massive volume of 4.09 million shares. The stock today also touched a new 52 week high $39.26. The company announced it will develop and offer individual Private Medical Insurance (PMI) to respond to the emerging needs of customers around the globe. The company, a world leader in global life, accident and health insurance and global expatriate benefits will provide local PMI for citizens in countries outside the United States as well as to individual expatriates and high net worth individuals.

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

Covidien Ltd. (NYSE:COV) is amongst the top gainer in the early few hours. The stock has spurted 3.76% and is trading at $51.31 with a massive volume of 3.38 million shares. The stock today also touched a new 52 week high $52.40.  The company said that fiscal first-quarter net income increased to $412 million, or 82 cents a share, from $386 million, or 76 cents a share, with sales rising to $2.75 billion from $2.56 billion. New products, increased volumes and favorable foreign exchange moves drove sales growth, and profit also was helped by benefits from its restructuring program. For the fiscal year, the operating margin is now expected to be in the 21% to 22% range, compared with prior guidance of 20% to 21%, and it sees free cash flow in excess of $1.5 billion from earlier guidance of approximately $1.4 billion. It still sees sales in fiscal 2010 up 6% to 9%, including foreign exchange at current rates and excluding Oxy ER sales from the 2009 base. Analysts polled by FactSet had expected earnings of 76 cents a share for the quarter and $3.30 for the year.

Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) climbed up 1.15% over its previous day’s price and now trades at $16.75 on a massive volume of 1.24 million shares.  The stock today also touched a new 52 week high $16.95. Amylin Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases.

About http://www.pennystockpickreport.com/

 The Penny Stock Report offers a stock newsletter on OTC, PINKSHEETS ,OTCBB, and AMEX Stocks. Our subscribers receive daily up to date stock information on midcap, smallcap penny stocks and also stocks that are traded at NASDAQ and NYSE stock exchange. If you wish to feature your organization on our website then you can contact us at the email given below.